Stocks › BSX
Boston Scientific Corporation (BSX) stock analysis
SKIP 8% confidence · analysed Oct 2, 2026
On Oct 2, 2026, our model rated Boston Scientific Corporation (BSX) SKIP with 8% confidence at a price of $43.23. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 52, close to the neutral 50 line, so momentum is balanced.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is about normal (0.8x the 20-day average).
Fundamentals
The PEG ratio is 0.61, which looks cheap relative to its expected growth.
The company reports a profit margin of 17.5% and revenue growth of +7.5%.
In its latest quarter it earned $0.86 per share, which beat the $0.83 analysts expected, with revenue +7.5% year over year.
Wall Street's average rating is 1.6 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $61.00.
The next earnings report is expected around Oct 28, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.08 (SKIP). Technicals: RSI 51.64, MACD bullish, price below SMA50. Fundamentals: PEG 0.61, margin 17.5%, revenue growth 7.5%. Financial results: YoY revenue +7.5%, last EPS surprise +3.6%, next earnings 2026-10-28. FinGPT news read: neutral. Memory: 4 prior look(s); 0% of directional calls matched later price. Reference price $43.23; no trade levels (SKIP).
Past ratings for BSX
Of the last 3 directional calls on BSX, 0 pointed the right way by the most recent analysis (0%). Past calls do not guarantee future results.
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 2, 2026 | SKIP | 8% | $43.23 | — | |
| Oct 1, 2026 | SKIP | 7% | $43.24 | -0.0% | |
| Sep 30, 2026 | WEAK BUY | 24% | $43.88 | -1.5% | ✘ wrong direction |
| Sep 29, 2026 | WEAK BUY | 12% | $44.11 | -2.0% | ✘ wrong direction |
| Sep 8, 2026 | WEAK BUY | 29% | $47.80 | -9.6% | ✘ wrong direction |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
CNC · COO · CVS · DVA · EVH · FTRE · HALO · HUM · IART · ICLR · IRWD · JNJ
Frequently asked questions
Is BSX a buy right now?
As of Oct 2, 2026, our automated model rates Boston Scientific Corporation (BSX) SKIP with 8% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Boston Scientific Corporation report earnings next?
The next earnings report is expected around Oct 28, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.